Clinician handoff
Ms
Designed for a 60-second scan in primary care. Use this to explain why this theory fits, what would weaken it, and which tests are most worth discussing.
Why this still fits
I want to evaluate whether my brain fog fits an MS-related cognitive pattern and whether there are neurologic clues that make this more urgent than a general fatigue workup.
What would weaken it
- -Are there focal neurologic symptoms here that make MS more plausible than sleep, depression, or medication effects?
- -Does heat or infection reliably worsen the cognitive pattern?
- -If MS is already diagnosed, what part of this looks disease-related versus sleep, mood, or medication overlap?
Key points to communicate
- •Please document what findings would confirm this cause versus lower confidence.
- •I want an evidence-first workup with clear follow-up criteria.
- •Please note which competing causes should be checked in parallel if results are inconclusive.
Tests and measurements to discuss
Need the fuller context? Use the test explainers for the measurement itself, or jump back to the tests section on the Ms page to see how the tests fit the whole pattern.
Brain MRI
What this helps clarify: Structural neuroimaging used to evaluate red flags and differential neurological causes.
Range context
Radiology report
How to use the result
Save the result with date and symptoms from the same week.
Neurology Evaluation
Neuropsychological Testing
MS Diagnosis (if not yet diagnosed)
MS diagnosis requires: evidence of CNS damage, dissemination in time and space (lesions in different locations developing at different times). The McDonald Criteria guide diagnosis.
What this helps clarify: MS diagnosis requires: evidence of CNS damage, dissemination in time and space (lesions in different locations developing at different times).
Cognitive Assessment
Cognitive impairment affects 40-70% of MS patients. Processing speed is most commonly affected. Assessment helps target rehabilitation.
What this helps clarify: Cognitive impairment affects 40-70% of MS patients.
Peer-reviewed references